LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals?

In This Article:

LeMaitre Vascular's (NASDAQ:LMAT) stock is up by a considerable 14% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we decided to study the company’s key performance indicators to see if they could be influencing the market. Specifically, we decided to study LeMaitre Vascular's ROE in this article.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.

View our latest analysis for LeMaitre Vascular

How To Calculate Return On Equity?

The formula for ROE is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for LeMaitre Vascular is:

12% = US$38m ÷ US$320m (Based on the trailing twelve months to June 2024).

The 'return' is the income the business earned over the last year. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.12.

What Is The Relationship Between ROE And Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

A Side By Side comparison of LeMaitre Vascular's Earnings Growth And 12% ROE

To begin with, LeMaitre Vascular seems to have a respectable ROE. Further, the company's ROE is similar to the industry average of 11%. This probably goes some way in explaining LeMaitre Vascular's moderate 11% growth over the past five years amongst other factors.

Next, on comparing LeMaitre Vascular's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 12% over the last few years.

past-earnings-growth
past-earnings-growth

Earnings growth is an important metric to consider when valuing a stock. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). This then helps them determine if the stock is placed for a bright or bleak future. What is LMAT worth today? The intrinsic value infographic in our free research report helps visualize whether LMAT is currently mispriced by the market.